Scientific article
Open access

Role of PAR-4 in ovarian cancer

Published inOncotarget, vol. 6, no. 26, p. 22641-22652
Publication date2015

Prostate apoptosis response-4 (PAR-4) is considered as a tumour suppressor due to its ability to selectively induce cell apoptosis in most cancer cells. However little is known about the role of PAR-4 in ovarian cancer. In this study, we investigated for the first time the role of PAR-4 in ovarian carcinogenesis. We showed that PAR-4 mRNA level is not significantly different between healthy and cancer ovarian cells. Immunohistochemistry on ovarian tissue showed that ovarian cancer cells are positive for PAR-4 nuclear and cytoplasmic staining whereas ovarian healthy cells are negative for PAR-4 nuclear staining. We then studied the role of PAR-4 in cell apoptosis. We determined that PAR-4 induces cell apoptosis in response to stimuli, in vitro, but is also involved in the relocation of GRP78 from endoplasmic reticulum to the cell surface of ovarian cancer cell line (SKOV-3 cells). In ovo, PAR-4 decreases ovarian tumour development and increases the response to taxol treatment. These observations suggest that PAR-4 is a very interesting therapeutic target against ovarian carcinogenesis.

Citation (ISO format)
MEYNIER, Sonia et al. Role of PAR-4 in ovarian cancer. In: Oncotarget, 2015, vol. 6, n° 26, p. 22641–22652. doi: 10.18632/oncotarget.4010
Main files (1)
Article (Published version)
ISSN of the journal1949-2553

Technical informations

Creation08/31/2015 1:49:00 PM
First validation08/31/2015 1:49:00 PM
Update time03/14/2023 11:35:37 PM
Status update03/14/2023 11:35:37 PM
Last indexation08/29/2023 7:06:57 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack